Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy

MLA

Seid Hamzic, et al. “Fluoropyrimidine Chemotherapy: Recommendations for DPYD Genotyping and Therapeutic Drug Monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy.” Swiss Medical Weekly, vol. 150, no. 4748, Nov. 2020. EBSCOhost, https://doi.org/10.4414/smw.2020.20375.

APA

Seid Hamzic, Stefan Aebi, Markus Joerger, Michael Montemurro, Marc Ansari, Ursula Amstutz, & Carlo Largiadèr. (2020). Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy. Swiss Medical Weekly, 150(4748). https://doi.org/10.4414/smw.2020.20375

Chicago

Seid Hamzic, Stefan Aebi, Markus Joerger, Michael Montemurro, Marc Ansari, Ursula Amstutz, and Carlo Largiadèr. 2020. “Fluoropyrimidine Chemotherapy: Recommendations for DPYD Genotyping and Therapeutic Drug Monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy.” Swiss Medical Weekly 150 (4748). doi:10.4414/smw.2020.20375.